REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021

Jun 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-06-14

Reporting Person: RYAN ARTHUR F (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-14	Common Stock	S	18	$522.41	Disposed	23673	Direct
2021-06-14	Common Stock	S	20	$523.59	Disposed	23653	Direct
2021-06-14	Common Stock	S	23	$524.49	Disposed	23630	Direct
2021-06-14	Common Stock	S	15	$525.63	Disposed	23615	Direct
2021-06-14	Common Stock	S	10	$526.48	Disposed	23605	Direct
2021-06-14	Common Stock	S	12	$527.63	Disposed	23593	Direct
2021-06-14	Common Stock	S	2	$528.37	Disposed	23591	Direct

Footnotes

F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).

F2: Represents volume-weighted average price of sales of 18 shares of Company stock on June 14, 2021 at prices ranging from $521.90 to $522.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 14, 2021 at each separate price.

F3: Represents volume-weighted average price of sales of 20 shares of Company stock on June 14, 2021 at prices ranging from $523.15 to $523.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 14, 2021 at each separate price.

F4: Represents volume-weighted average price of sales of 23 shares of Company stock on June 14, 2021 at prices ranging from $524.01 to $524.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 14, 2021 at each separate price.

F5: Represents volume-weighted average price of sales of 15 shares of Company stock on June 14, 2021 at prices ranging from $525.00 to $525.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 14, 2021 at each separate price.

F6: Represents volume-weighted average price of sales of 10 shares of Company stock on June 14, 2021 at prices ranging from $526.04 to $526.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 14, 2021 at each separate price.

F7: Represents volume-weighted average price of sales of 12 shares of Company stock on June 14, 2021 at prices ranging from $527.00 to $527.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 14, 2021 at each separate price.

F8: Represents volume-weighted average price of sales of 2 shares of Company stock on June 14, 2021 at prices ranging from $528.16 to $528.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 14, 2021 at each separate price.